TLR4 and hepatocellular carcinoma: Altogether, these findings demonstrated that the potential action of gut microbiota-derived PAMPs (including LPS) as activators of hepatic TLR4 contributes to the development of steatohepatitis-related HCC in the mouse via macrophage-mediated inflammation [18].